A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves A[beta]^sub 25-35^-impaired mouse cognitive function
Rationale The mechanism involved in AD is complex, which has prompted to develop compounds that could simultaneously interact with several potential targets. Here, we report a new synthesized compound SCR-1693 which is designed to target both AChE and calcium channels that are potential for AD thera...
Gespeichert in:
Veröffentlicht in: | Psychopharmacology 2016-02, Vol.233 (4), p.599 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!